Net Cash Provided by (Used in) Financing Activities in USD of NRX Pharmaceuticals, Inc. from Q4 2017 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NRX Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2017 to Q1 2025.
  • NRX Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $7.59M, a 1820% increase year-over-year.
  • NRX Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $7.49M, a 20.7% increase from 2023.
  • NRX Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6.2M, a 80.8% decline from 2022.
  • NRX Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $32.2M, a 49.2% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

NRX Pharmaceuticals, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $7.59M +$7.19M +1820% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q1 2024 $395K -$2.15M -84.5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q1 2023 $2.55M -$20.4M -88.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $23M +$8.55M +59.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $14.4M +$40.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 -$25.8M -$26.6M -3335% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-21
Q1 2019 $797K +$8.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 -$7.5M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $69.6M Sep 18, 2017 Dec 31, 2017 10-K 2019-03-15

NRX Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $7.49M +$1.28M +20.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-14
2023 $6.2M -$26M -80.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-14
2022 $32.2M -$31.2M -49.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $63.5M +$60.2M +1853% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $3.25M +$42.7M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$39.5M -$40.1M -5882% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-05-14
2018 $683K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.